Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
2.82
Oct 28 • 3:59 PM ET Dollar change+0.03 Percentage change(1.08%)
Aftermarket Close
2.88
Aftermarket • 5:00 PM ET Dollar change+0.06 Percentage change(2.13%)
Index
-
Market Cap
46.42M
Enterprise Value
31.57M
Income
-15.48M
Sales
17.51M
Book/sh
2.24
Cash/sh
0.92
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
60
IPO
Jul 26, 2016
P/E
-
Forward P/E
-
PEG
-
P/S
2.65
P/B
1.26
P/C
3.06
P/FCF
-
EV/EBITDA
-
EV/Sales
1.80
Quick Ratio
4.30
Current Ratio
8.71
Debt/Eq
0.01
LT Debt/Eq
0.00
Option/Short
Yes / Yes
EPS (ttm)
-0.94
EPS next Y
-0.11
EPS next Q
-0.06
EPS this Y
-68.62%
EPS next Y
85.80%
EPS next 5Y
-
EPS past 3/5Y
- -2.60%
Sales past 3/5Y
-14.86% 23.47%
EPS Y/Y TTM
-1719.88%
Sales Y/Y TTM
-53.40%
EPS Q/Q
-737.01%
Sales Q/Q
-68.69%
Insider Own
18.67%
Insider Trans
5.95%
Inst Own
25.11%
Inst Trans
-3.97%
ROA
-30.94%
ROE
-34.83%
ROIC
-41.93%
Gross Margin
36.39%
Oper. Margin
-75.72%
Profit Margin
-88.45%
SMA20
-1.95%
SMA50
-7.73%
SMA200
-20.79%
Trades
Shs Outstand
16.46M
Shs Float
13.39M
52W High
5.49 -48.63%
52W Low
2.66 6.02%
Volatility
5.10% 4.62%
ATR (14)
0.14
RSI (14)
43.01
Beta
1.18
Rel Volume
3.37
Avg Volume
29.26K
Volume
98,529
Perf Week
-1.40%
Perf Month
-8.14%
Perf Quarter
-2.42%
Perf Half Y
-27.69%
Perf YTD
-29.15%
Perf Year
-13.76%
Perf 3Y
28.77%
Perf 5Y
-28.79%
Perf 10Y
-55.24%
Prev Close
2.79
Price
2.82
Change %
1.08%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sachetta EricDirectorAug 28 '26Buy3.4437,537129,015267,480Aug 31 12:35 PM
Sachetta EricDirectorAug 31 '26Buy3.5427,30496,602294,784Aug 31 12:35 PM
Sachetta EricDirectorAug 27 '26Buy3.1810,92534,752229,943Aug 28 02:29 PM
Sachetta EricDirectorAug 26 '26Buy3.299,70831,930219,018Aug 28 02:29 PM
Sachetta EricDirectorAug 24 '26Buy3.2534,697112,904209,310Aug 25 09:26 AM
Sardano Joseph CCHIEF EXECUTIVE OFFICERAug 20 '26Buy3.0220,00060,4861,220,293Aug 24 04:00 PM
Sachetta EricDirectorAug 20 '26Buy3.1324,00075,072167,613Aug 24 03:08 PM
Sachetta EricDirectorAug 21 '26Buy3.257,00022,778174,613Aug 24 03:08 PM
Sachetta EricDirectorMay 12 '26Buy3.331,5005,002143,613May 12 01:53 PM
Sachetta EricDirectorFeb 24 '26Buy3.812,0007,620142,113Feb 26 09:25 AM
Sachetta EricDirectorNov 21 '25Buy3.937,00027,510140,113Nov 21 02:28 PM
Sachetta EricDirectorNov 13 '25Buy4.502,50011,250133,113Nov 20 02:03 PM
Sardano Joseph CCHIEF EXECUTIVE OFFICERNov 18 '25Buy4.0325,000100,7501,200,293Nov 19 09:34 AM
Sardano MichaelPRESIDENT AND GENERAL COUNSELNov 18 '25Buy3.801,0003,800118,839Nov 19 09:15 AM
Sardano MichaelPRESIDENT AND GENERAL COUNSELNov 11 '25Buy4.261,0004,260117,839Nov 12 09:53 AM
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
Co-FounderMr. Joseph C. Sardano
PresidentMr. Michael J. Sardano J.D.
Chief Financial OfficerMr. Javier Rampolla
Chief Operating OfficerMs. Magdalena Martinez
Chief Technology OfficerMr. Carlton Chow